EUVIMEDEUVIMED entdecken
Open Access

A novel DNA methylation-based surrogate biomarker for chronic systemic inflammation (Inflammation Latent Variable Methylation Surrogate, InfLaMeS)

Helen C S Meier iD, Eric T Klopack iD, Mateo P Farnia iD, Belinda Hernandez iD, Colter Mitchell, Jessica D Faul iD, Cathal McCrory iD, Rose Anne Kenny, Eileen M Crimmins

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 06.11.2025 · 80 (12)

DOI: 10.1093/gerona/glaf202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, online erschienen am 24.09.2025. Verfasst von Helen C S Meier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: DNA Methylation, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic low-grade systemic inflammation is a risk factor for chronic diseases and mortality and is an important biomarker in health research. DNA methylation (DNAm) surrogate biomarkers are valuable exposure, risk factor, and health outcome predictors in studies where the measures cannot be measured directly and often perform as well or better than direct measures. We generated a DNAm surrogate biomarker for chronic, systemic inflammation from a systemic inflammation latent variable of 7 inflammatory markers and evaluated its performance relative to measured inflammatory biomarkers in predicting several age-associated outcomes of interest, including mortality, activities of daily living, and multimorbidity in the Health and Retirement Study (HRS). The DNAm surrogate, Inflammation Latent Variable Methylation Surrogate (InfLaMeS), correlated with 7 individual inflammation markers (r = −0.2-0.6) and had similar or stronger associations with multimorbidity, disability, and 4-year mortality in HRS compared to the systemic inflammation latent variable measure when predicting multimorbidity, disability, and 4-year mortality in HRS. Findings were validated in an external cohort, the Irish Longitudinal Study of Ageing. These results suggest that InfLaMeS provides a robust alternative to measured blood-chemistry measures of inflammation with broad research applicability in instances where values of inflammatory markers are not measured but DNAm data are available.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationInflammationHumansFemaleMaleBiomarkersAgedChronic DiseaseLongitudinal StudiesMultimorbidityAged, 80 and overMiddle AgedActivities of Daily Living

Stichwörter der Autor:innen

DNA methylationHealth and Retirement StudyInflammagingInflammation

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan, USA.
  • Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
  • Human Development and Family Sciences, University of Texas at Austin, Austin, Texas, USA.
  • The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland.

ORCID-Profile: Helen C S Meier, Eric T Klopack, Mateo P Farnia, Belinda Hernandez, Jessica D Faul, Cathal McCrory

Förderung

  • NIA NIH HHS
  • National Institute on Aging of the National Institutes of Health

Zitieren

APA

Meier, H. C. S., Klopack, E. T., Farnia, M. P., Hernandez, B., Mitchell, C., Faul, J. D., McCrory, C., Kenny, R. A., & Crimmins, E. M. (2025). A novel DNA methylation-based surrogate biomarker for chronic systemic inflammation (Inflammation Latent Variable Methylation Surrogate, InfLaMeS). The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 80(12). https://doi.org/10.1093/gerona/glaf202

Vancouver

Meier HCS, Klopack ET, Farnia MP, Hernandez B, Mitchell C, Faul JD, et al. A novel DNA methylation-based surrogate biomarker for chronic systemic inflammation (Inflammation Latent Variable Methylation Surrogate, InfLaMeS). The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025;80(12). doi:10.1093/gerona/glaf202

BibTeX
@article{Meier2025,
  author = {Meier, Helen C S and Klopack, Eric T and Farnia, Mateo P and Hernandez, Belinda and Mitchell, Colter and Faul, Jessica D and McCrory, Cathal and Kenny, Rose Anne and Crimmins, Eileen M},
  title = {A novel DNA methylation-based surrogate biomarker for chronic systemic inflammation (Inflammation Latent Variable Methylation Surrogate, InfLaMeS)},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  volume = {80},
  number = {12},
  doi = {10.1093/gerona/glaf202}
}
Kostenlos starten →